Advanced Drug Delivery 2 - liposomes Flashcards

1
Q

What are liposomes and their size

A
  • Microparticulate or colloidal drug carriers
  • Vesicular structures composed of one or more lipid bilayers encapsulating a central aqueous core
  • The lipid molecules are normally phospholipids
  • Size: 0.05 – 5 µm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chemical structure of phospholipids

A

Contains
- 2 hydrophobic tails of fatty acid
- 1 hydrophilic head of phosphate moiety joined together by an alcohol or glycerol molecule

  • This structural arrangement allows them to form lipid bilayers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Characteristics of fatty acids

A
  • fatty = lipophilic
  • acid = COOH carboxylic group
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What charge is phosphate

A

Negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phosphatidylcholine (PC) derivatives

A
  • Phosphate group is -
  • PC is +
  • So overall neutral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Phosphatidylethanolamine (PE) derivatives

A
  • Phosphate group is -
  • PE is +
  • So overall neutral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Phosphatidylserine (PS) derivatives

A
  • Phosphate group is -
  • PS has one + and one -
  • So overall negative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Phosphatidylglycerol (PG) derivatives

A
  • Phosphate group is -
  • PG is -
  • So overall negative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Discuss cholesterol in the context of liposomes

A
  • Component that is normally added to liposomes
  • Cholesterol is largely hydrophobic
  • But presence of OH group confers some hydrophilicity = amphiphilic molecule
  • This allows cholesterol to insert itself in the bilayer with the hydrophilic part (OH group) close to polar head and hydrophobic part next to lipophilic chains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The presence of OH group and the properties of liposomes

A
  • The OH groups can form hydrogen bonds with other molecules in the liposome membrane which can increase its stability and rigidity.
  • Can impact the solubility and permeability of the liposome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the main transition temperature, TM

A

Phospholipid membranes have a parameter called TM

Below the TM:
- cholesterol has a fluidising, disorganising action
- phospholipids bilayer is less fluid, more gel like

Above TM:
- cholesterol has a condensing action
- a lot of energy in system
- bilayer very fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Conformation of a lisaphospholipid

A
  • e.g. detergents
  • Geometry: like a cone
  • Therefore most thermodynamically stable conformation is a micelle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Conformation of double chain phospholipids with LARGE head groups

A
  • e.g. PC
  • Large polar head and smaller tails that occupy smaller volume
  • Geometry: like truncated cone
  • Therefore, most thermodynamically stable conformation is bilayer vesicle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Conformation of double chain phospholipid with SMALL head groups

A
  • e.g. PE
  • Geometry: like a cyclinder
  • Therefore, most thermodynamically stable conformation is planar bilayer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Conformation of phospholipid with two chains and unsaturation

A
  • e.g. Phosphatidylethanol amine (unsaturated)
  • Double bonds = tails spreads wider
  • Geometry: Inverted truncated cone
  • Therefore, most thermodynamically stable conformation is inverted micelle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Classification of Liposomes

A
  • SUV - small unilamellar vesicles
  • LUV - large unilamellar vesicles
  • MLV - multilamellar vesicles
  • MVV - multi vesicular vesicles
17
Q

SUV

A

small unilamellar vesicle (SUV)

18
Q

LUV

A

large unilameller vesicles (LUV)

19
Q

MLV

A

multilamellar vesicles

20
Q

MVV

A

multi vesicular vesicles

21
Q
  • How can liposomes be used as drug carriers?
A
  • Can carry both hydrophobic and hydrophilic drugs
  • Encapsulate the drug within the liposome; which protects from degradation and improves solubility in water
  • Target specific cells/tissues; improves efficiency of drug and reduce SE
  • Liposomes can be designed to release the drug in a controlled manner
22
Q

Where hydrophobic and hydrophilic drugs inserts themselves in the liposomes

A
  • hydrophobic drugs = hydrophobic tails (middle of bilayer)
  • hydrophilic drugs = aqueous core
23
Q

4 Characteristics of liposomes

A
  1. Drug:lipid ratio
  2. Encapsulation efficiency
  3. Size
  4. Lamellarity
24
Q

Challenge of liposomes

A
  • Bilayers form spontaneously after addition of water to phospholipids.

The challenge is forming stable vesicles with the desired:

  • Size
  • Physio-chemical properties
  • A high drug encapsulation frequency
25
Q

What is high drug encapsulation efficiency

A
  • Measure of how efficiently the drug is incorporated into the liposome
  • Allowing for less liposomes to be administered (based on efficacy)
26
Q

Typical methodology of preparing liposomes

A
  1. Lipid hydration
  2. Selection of liposomes based on size
  3. Remove the non-encapsulated drug
27
Q

Thin layer evaporation method of preparing liposomes

A
  1. Mixture of phospholipids dissolved in organic solvent
  2. Solvent evaporation leads to phospholipid film in flask
  3. Add water-based buffer solution into phospholipid film for lipid hydration
  4. Stirring; temperature > transition temperature
  5. This causes film hydration under stirring
  6. Liposome will start forming
28
Q

Additional methods to form desired lysosome

A

e.g. Sonification and extrusion

29
Q

What is sonification

A
  1. Prepare a solution of PC in chloroform
  2. Place it in a round bottom flask and evaporate solvent
  3. Add an aqueous solution of the drug
  4. Put liposome mixture in an ultrasound bath to reduce particle size
30
Q

What is extrusion

A
  • Process carried out through polycarbonate filters
  • to control size under pressure by controlling size of pores in filter
31
Q

Administration routes of liposomes

A
  • Parenteral
  • Pulmonary
  • Oral
  • Topical
32
Q

Biodistribution of liposomes and PK of the API depend on

A
  • size of vesicles
  • composition of bilayer
  • fluidity of bilayer
33
Q

Stability of issues before administration and solution

A
  • Oxidation of lipophilic chains
  • Hydrolysis and formation of lysophospholipids
  • Tendency to form aggregates
  • Solution: freeze drying
34
Q

Stabilities issues of liposomes after administration and solution

A
  • Captured by macrophages
  • Solution: long circulating liposomes (LCL) aka sterically stabilised liposomes (stealth)
  • attach PEG chains, macrophages will not recognise them, allowing them to circulate for longer
35
Q

4 types of liposomes based on composition and application

A
  1. Conventional liposomes
  2. Sterically stabilised (stealth) liposomes
  3. Immunoliposomes (antibody targeted)
  4. Cationic liposomes (for gene delivery)
36
Q

Clinical applications of liposomes

A
  1. Abelcet
  2. AmBisome
  3. Doxil
37
Q

What is Abelcet

A
  • Contains amphotericin B, anti fungal with good activity BUT nephrotoxic
  • Liposomal formulation less toxic
  • Sodium chloride added for tonicity
38
Q

What is AmBisome

A
  • Amphotericin B encapsulated in liposomes
  • Conventional liposomes for parenteral use
  • SUV (small unilamellar vesicles) 50-100nm
  • Lower toxicity than normal amphotericin B
39
Q

What is Doxil

A
  • Liposomal encapsulated doxorubicin
  • Doxil is an anticancer agent that is very cardiotoxic
  • Liposomes reduce toxicity
  • Contain PEGlyated liposomes (long circulating liposomes)